Immunological aspects in chronic lymphocytic leukemia (CLL) development

por García-Muñoz, Ricardo, Roldan Galiacho, Verónica, Llorente, Luis
Publicado 2012

GALLIUM trial: the tortoise (rituximab) and the hare (obinutuzumab) race

por García-Muñoz, Ricardo, Anton-Remirez, Judit, Nájera, María Josefa, Gutierrez-Gamarra, Elena, Peralta, Raisa, Feliu, Jesús
Publicado 2019

Serology-based therapeutic strategy in SARS-CoV-2-infected patients

por Garcia-Muñoz, Ricardo, Farfán-Quiroga, Giovanna, Ruiz-de-Lobera, Noemí, Feliu, Jesus, Anton-Remirez, Judith, Nájera Irazu, Maria José, Lisa Catón, Valentín, Oteo-Revuelta, José Antonio
Publicado 2021

Safety of switching from intravenous to subcutaneous rituximab during first‐line treatment of patients with non‐Hodgkin lymphoma: the Spanish population of the MabRella study

por García‐Muñoz, Ricardo, Quero, Cristina, Pérez‐Persona, Ernesto, Domingo‐García, Abel, Pérez‐López, Cristina, Villaescusa‐de‐la‐Rosa, Teresa, Martínez‐Castro, Ana M., Arguiñano‐Pérez, José M., Parra‐Cuadrado, Juan F., Panizo, Carlos
Publicado 2019

Peripheral blood natural killer cell depletion is associated with severe pneumonia in coronavirus disease-2019 (COVID-19)

por Garcia-Muñoz, Ricardo, Feliu, Jesus, Anton-Remirez, Judit, Metola, Luis, Sosa-Campos, Enrique, Sanz, Maria-Pilar, Farfan, Giovanna, Labrador-Sanchez, Eztizen, Ibarra, Valvanera, Peña, Jose-Luis, Pascual, Ana, Hermosa, María-Jesús, Blasco, Miriam, Llerena-Garcia, Lorena, Najera, María-José, Oteo, José Antonio
Publicado 2021

Battle of Thermopylae: 300 Spartans (natural killer cells plus obinutuzumab) versus the immortal warriors (chronic lymphocytic leukemia cells) of Xerxes’ army

por García-Muñoz, Ricardo, Nájera, María-Josefa, Feliu, Jesús, Antón-Remírez, Judith, Ramalle-Gómara, Enrique, Marín-Gorricho, Raquel, Peralta, Raisa, Gutiérrez-Gamarra, Elena, Nuñez-Rodriguez, Jessica, Zafra-Morales, Ricardo, Aguinaga, Lorea, Nebot-Villacampa, María-Jose, Hernandez-Pérez, Prisma-Monserrat, Farfán-Quiroga, Giovanna, Panizo, Carlos, Domínguez-Garrido, Elena
Publicado 2019

Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics

por Robles, Eloy F., Mena-Varas, Maria, Barrio, Laura, Merino-Cortes, Sara V., Balogh, Péter, Du, Ming-Qing, Akasaka, Takashi, Parker, Anton, Roa, Sergio, Panizo, Carlos, Martin-Guerrero, Idoia, Siebert, Reiner, Segura, Victor, Agirre, Xabier, Macri-Pellizeri, Laura, Aldaz, Beatriz, Vilas-Zornoza, Amaia, Zhang, Shaowei, Moody, Sarah, Calasanz, Maria Jose, Tousseyn, Thomas, Broccardo, Cyril, Brousset, Pierre, Campos-Sanchez, Elena, Cobaleda, Cesar, Sanchez-Garcia, Isidro, Fernandez-Luna, Jose Luis, Garcia-Muñoz, Ricardo, Pena, Esther, Bellosillo, Beatriz, Salar, Antonio, Baptista, Maria Joao, Hernandez-Rivas, Jesús Maria, Gonzalez, Marcos, Terol, Maria Jose, Climent, Joan, Ferrandez, Antonio, Sagaert, Xavier, Melnick, Ari M., Prosper, Felipe, Oscier, David G., Carrasco, Yolanda R., Dyer, Martin J. S., Martinez-Climent, Jose A.
Publicado 2016